These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Aranda E; Cervantes A; Dorta J; Blanco E; Fernández-Martos C; Cruz-Hernandez JJ; Carrato A; Gonzalez-Mancha R; García-Conde J; Díaz-Rubio E Cancer; 1995 Aug; 76(4):559-63. PubMed ID: 8625147 [TBL] [Abstract][Full Text] [Related]
25. Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial. Burch PA; Ghosh C; Schroeder G; Allmer C; Woodhouse CL; Goldberg RM; Addo F; Bernath AM; Tschetter LK; Windschitl HE; Cobau CD Am J Clin Oncol; 2000 Oct; 23(5):534-7. PubMed ID: 11039519 [TBL] [Abstract][Full Text] [Related]
26. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. Moertel CG; Gunderson LL; Mailliard JA; McKenna PJ; Martenson JA; Burch PA; Cha SS J Clin Oncol; 1994 Jan; 12(1):21-7. PubMed ID: 8270979 [TBL] [Abstract][Full Text] [Related]
27. [Preoperative concurrent radiochemotherapy for cancer of the rectum]. Berger C; Kirscher S; Félix-Faure C; Chauvet B; Vincent P; Brewer Y; Reboul F Cancer Radiother; 1998; 2(3):260-5. PubMed ID: 9749124 [TBL] [Abstract][Full Text] [Related]
28. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer. Luo HY; Xu RH; Zhang L; Li YH; Shi YX; Lin TY; Han B; Wang F; Qiu MZ; He YJ; Guan ZZ Chemotherapy; 2008; 54(3):228-35. PubMed ID: 18560231 [TBL] [Abstract][Full Text] [Related]
29. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group. Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994 [TBL] [Abstract][Full Text] [Related]
30. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244 [TBL] [Abstract][Full Text] [Related]
31. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. Anscher MS; Lee C; Hurwitz H; Tyler D; Prosnitz LR; Jowell P; Rosner G; Samulski T; Dewhirst MW Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):719-24. PubMed ID: 10837956 [TBL] [Abstract][Full Text] [Related]
33. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study. Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086 [TBL] [Abstract][Full Text] [Related]
34. Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. Micke O; Hesselmann S; Bruns F; Horst E; Devries A; Schüller P; Willich N; Schäfer U Anticancer Res; 2005; 25(3A):1523-30. PubMed ID: 16033054 [TBL] [Abstract][Full Text] [Related]
35. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer. Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma. Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186 [TBL] [Abstract][Full Text] [Related]
37. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Carducci MA; Abrams RA; Yeo CJ; Hruban RH; Zahurak ML; Cameron JL; Grochow LB Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):143-50. PubMed ID: 8641911 [TBL] [Abstract][Full Text] [Related]
38. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Nywening TM; Wang-Gillam A; Sanford DE; Belt BA; Panni RZ; Cusworth BM; Toriola AT; Nieman RK; Worley LA; Yano M; Fowler KJ; Lockhart AC; Suresh R; Tan BR; Lim KH; Fields RC; Strasberg SM; Hawkins WG; DeNardo DG; Goedegebuure SP; Linehan DC Lancet Oncol; 2016 May; 17(5):651-62. PubMed ID: 27055731 [TBL] [Abstract][Full Text] [Related]
39. A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study. Whitehead RP; Benedetti JK; Abbruzzese JL; Ardalan B; Goodwin JW; Balcerzak SP; Samlowski WE; Lenz HJ; Macdonald JS Invest New Drugs; 2004 Aug; 22(3):335-41. PubMed ID: 15122082 [TBL] [Abstract][Full Text] [Related]
40. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation. Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]